FI87213B - Foerfarande foer framstaellning av antikolinerga foereningar. - Google Patents

Foerfarande foer framstaellning av antikolinerga foereningar. Download PDF

Info

Publication number
FI87213B
FI87213B FI874937A FI874937A FI87213B FI 87213 B FI87213 B FI 87213B FI 874937 A FI874937 A FI 874937A FI 874937 A FI874937 A FI 874937A FI 87213 B FI87213 B FI 87213B
Authority
FI
Finland
Prior art keywords
compound
formula
methyl
azabicyclo
carboxy
Prior art date
Application number
FI874937A
Other languages
English (en)
Finnish (fi)
Other versions
FI874937A0 (fi
FI87213C (sv
FI874937A (fi
Inventor
Nicholas S Bodor
Richard H Hammer
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of FI874937A0 publication Critical patent/FI874937A0/fi
Publication of FI874937A publication Critical patent/FI874937A/fi
Publication of FI87213B publication Critical patent/FI87213B/fi
Application granted granted Critical
Publication of FI87213C publication Critical patent/FI87213C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/02Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/10Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)

Claims (7)

1. Förfarande för framställning av farmakologiskt användbara föreningar med formeln (I) R4-0-C-CH-^ ^ (I) COOR1 där R1 är en rak eller förgrenad alkyl eller cykloalky1grupp med 1-8 kolatomer, och R4 är Rl RS N \ v\ N. \ --\ eller __ där är en alkylgrupp med 1-5 kolatomer eller kvaternära ammoniumsalt av en förening med formeln I med en förening med formeln R?Y, där R^ är en alkylgrupp med 1-5 kolatomer och Y är en farmaceutiskt godtagbar anjon, kännetecknat därav, att en syraklorid med formeln I /r\ Cl-C-CH-(/ \) I ! \=/ COOR-1· där R·^ är ovan definierad, omsätts med en alkohol med formeln 8721 3 58 R5 R5^ OH θ' OH där är ovan definierad, och om ett kvaternärt salt av en fö-rening med formeln (I) önskas kvatern?seras den erhällna föreningen med formeln (I) med en alkylerings- förening med formel R1 2Y, där R2 och Y är ovan definierade.
2. Förfarande enligt patentkravet 1, kännetecknat därav, att den framställda föreningen med formeln (I) är etyl (±)~(α-karboxi)-8-mety1-8-azabicyklo[3.2.1]okt-3-yl-bensenacetatdimetylsulfat.
3. Förfarande enligt patentkravet 1, kännetecknat därav, att den framställda föreningen med formeln (I) är butyl (±)-(α-karboxi)-8-mety1-8-azabicyklo[3.2.1]okt-3-yl-bensenacetatdimetylsulfat.
4. Förfarande enligt patentkravet 1, kännetecknat därav, att den framställda föreningen med formeln (I) är cyklohexy1 (±)-(α-karboxi)-8-mety1-8-azabicyklo[3.2.1]okt-3-y1-bensenacetatdimety 1 sul fat.
5. Förfarande enligt patentkravet 1, kännetecknat därav, att den framställda föreningen med formeln (I) är etyl (±)-(α-karboxi)-6,7-epoxi-8-mety1-8-azabicyklo[3.2.1]okt- 3-yl-bensenacetatdimetylsulfat. Förfarande enligt patentkravet 1, kännetecknat 2 därav, att den framställda föreningen med formeln (I) är 59 8721 3 propyl (±) - (α-karboxi)-6,7-epoxi-8-mety1-8-azabicyklo[3.2.1]-okt-3-yl-bensenacetatdimety1sulfat.
7. Förfarande enligt patentkravet 1, kännetecknat därav, att den framställda föreningen med formeln (I) är butyl (±)-(a-karboxi)-6,7-epoxi-8-mety1-8-azabicyklo[3.2.1]-okt-3-yl-bensenacetatdimetylsulfat.
FI874937A 1986-03-17 1987-11-09 Förfarande för framställning av antikolinerga föreningar FI87213C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US83994186A 1986-03-17 1986-03-17
US83994186 1986-03-17
PCT/US1987/000533 WO1987005603A1 (en) 1986-03-17 1987-03-17 Anticholinergic compounds, pharmaceutical compositions and method of treatment
US8700533 1987-03-17

Publications (4)

Publication Number Publication Date
FI874937A0 FI874937A0 (fi) 1987-11-09
FI874937A FI874937A (fi) 1987-11-09
FI87213B true FI87213B (fi) 1992-08-31
FI87213C FI87213C (sv) 1992-12-10

Family

ID=25281041

Family Applications (1)

Application Number Title Priority Date Filing Date
FI874937A FI87213C (sv) 1986-03-17 1987-11-09 Förfarande för framställning av antikolinerga föreningar

Country Status (14)

Country Link
EP (1) EP0238982B1 (sv)
JP (1) JP2672311B2 (sv)
KR (1) KR900007218B1 (sv)
AT (1) ATE86622T1 (sv)
CA (1) CA1328106C (sv)
DE (1) DE3784531T2 (sv)
DK (1) DK170560B1 (sv)
ES (1) ES2044851T3 (sv)
FI (1) FI87213C (sv)
IE (1) IE60645B1 (sv)
NO (1) NO874765L (sv)
NZ (1) NZ219653A (sv)
WO (1) WO1987005603A1 (sv)
ZA (1) ZA871948B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR046225A1 (es) * 2003-11-04 2005-11-30 Glaxo Group Ltd Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
US20080027094A1 (en) * 2004-08-30 2008-01-31 Ono Pharmaceutical Co., Ltd. Tropane Compounds and Pharmaceutical Compositions Comprising the Same as an Active Ingredient
CN113321648B (zh) * 2021-05-21 2022-02-11 常州康普药业有限公司 一种硫酸阿托品的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2814623A (en) * 1955-12-05 1957-11-26 Upjohn Co Certain esters of n-methyl scopolamine quaternary ammonium salts
DE1670048C3 (de) * 1966-01-26 1980-09-04 C.H. Boehringer Sohn, 6507 Ingelheim Neue Norscopolaminderivate
NL7002588A (sv) * 1969-03-04 1970-09-08
US3998815A (en) * 1974-06-24 1976-12-21 Interx Research Corporation 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts

Also Published As

Publication number Publication date
FI874937A0 (fi) 1987-11-09
DE3784531T2 (de) 1993-06-24
DK170560B1 (da) 1995-10-23
IE60645B1 (en) 1994-08-10
IE870698L (en) 1987-09-17
JP2672311B2 (ja) 1997-11-05
KR880701230A (ko) 1988-07-26
DE3784531D1 (de) 1993-04-15
KR900007218B1 (ko) 1990-10-05
AU595307B2 (en) 1990-03-29
DK567887A (da) 1987-10-30
ES2044851T3 (es) 1994-01-16
ZA871948B (en) 1987-09-07
WO1987005603A1 (en) 1987-09-24
JPS63502898A (ja) 1988-10-27
AU7203187A (en) 1987-10-09
NO874765L (no) 1988-01-14
NO874765D0 (no) 1987-11-16
FI87213C (sv) 1992-12-10
FI874937A (fi) 1987-11-09
CA1328106C (en) 1994-03-29
ATE86622T1 (de) 1993-03-15
EP0238982B1 (en) 1993-03-10
EP0238982A1 (en) 1987-09-30
NZ219653A (en) 1990-02-26
DK567887D0 (da) 1987-10-30

Similar Documents

Publication Publication Date Title
Clarke et al. Compounds affecting the central nervous system. 4. 3. beta.-phenyltropane-2-carboxylic esters and analogs
EP0023576B1 (en) 7- and 7,8-substituted 4,5-alpha-epoxymorphinan-6-ones and therapeutically active compositions containing them
JPS6363544B2 (sv)
JP4532109B2 (ja) 新規オリパビン誘導体および医薬としてのその使用
EP2964611B1 (en) Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
PT88656B (pt) Processo para a preparacao de derivados 4-aminopiridina
FI87213B (fi) Foerfarande foer framstaellning av antikolinerga foereningar.
WO1990012574A1 (en) Dopamine agonist compounds
WO2013020229A1 (en) Tetrahydroprotoberbine compounds and uses thereof in the treatment of neurological, psychiatric and neurodegenerative diseases
US6455543B1 (en) Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies
Ji et al. Synthesis and pharmacological effects of new, N‐substituted soft anticholinergics based on glycopyrrolate
DD219765A5 (de) Verfahren zur herstellung von substituierten hexahydropyrrolo (-1,2-a)-chinolin-, hexahydro-1h-pyrido (1,2-a)chinolin-, hexahydrobenzo(e)inden- und octahydrophenanthren-zns-mitteln
Lenz Synthesis of 7-oxygenated aporphine alkaloids from a 1-benzylideneisoquinoline enamide
EP3768679B1 (en) Biased potent opioid-like agonists as improved medications to treat chronic and acute pain and methods of using the same
AU595307C (en) Anticholinergic compounds, pharmaceutical compositions and method of treatment
Goldberg et al. Bicyclic lactones derived from kainic acid as novel selective antagonists of neuroexcitatory amino acids
CH675723A5 (sv)
CH666031A5 (de) Naphthoxazine, ihre herstellung und pharmazeutische zusammensetzungen.
JPH09509398A (ja) オクタヒドロベンゾ[f]キノリン系受容体アゴニストおよびアンタゴニスト
US7368443B2 (en) 2,6-disubstituted piperidines and piperazine compounds
CH658656A5 (de) Neue eburnamenin-14-carbonsaeure-derivate, verfahren zu ihrer herstellung und die neuen verbindungen enthaltende arzneimittelpraeparate.
US20200325157A1 (en) Novel Thiophene Compounds for Long-Acting Injectable Compositions and Related Methods
US3466291A (en) 4(2-dialkylaminoethoxy or 2-piperidinoethoxy) - 9,10 - dihydro benzo(4,5)cyclohepta(1,2-b)thiophene derivatives
WO1993024471A1 (en) Substituted naphthoxazines useful as dopaminergics
KR800000537B1 (ko) 아미노-페닐-에탄올아민의 제조방법

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: UNIVERSITY OF FLORIDA